Statera License Agreement - Additional Information (Details)	Jun. 18, 2025 USD ($)	Mar. 28, 2025 USD ($)	Feb. 11, 2025 USD ($) $ / yr
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Transaction cost			$ 243,000
License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Milestone payments			1,750,000
License Agreement \| Statera Biopharma, Inc.
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
License fee			1,500,000
Cash consideration			300,000
Stock consideration			$ 1,200,000
Lease negotiation per year \| $ / yr			1
License Agreement \| Neutropenia indication
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Milestone payments		$ 500,000
License Agreement \| Licensed technology
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Milestone payments		$ 500,000
A&R License Agreement \| Statera Biopharma, Inc.
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Increase in lien held	$ 5,600,000
Percentage of milestone payments agreed	20.00%
A&R License Agreement \| Avenue Venture Opportunities Fund, L.P.
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of milestone payments agreed	80.00%